66215-232 : Tracleer 32 mg Oral Tablet, Soluble


NDC: 66215-232
Labeler: Actelion Pharmaceuticals Us, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tracleer
Dosage Form: Oral Tablet, Soluble
Application #: NDA209279
Rev. Date: 


NDC Package Codes:

  • 66215-232-56: 4 BLISTER PACK IN 1 CARTON (66215‑232‑56) > 14 TABLET, SOLUBLE IN 1 BLISTER PACK (66215‑232‑14)

Active Ingredients:

  • Bosentan

Dosage Strength:

  • 32 mg

Pharmaceutical Classes:

  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Endothelin Receptor Antagonist [EPC]
  • Endothelin Receptor Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 66215-101 Tracleer 62.5 mg Oral Tablet by Actelion Pharmaceuticals Us, Inc.
  • 66215-102 Tracleer 125 mg Oral Tablet by Actelion Pharmaceuticals Us, Inc.
  • 66215-103 Tracleer 32 mg Oral Tablet, Soluble by Actelion Pharmaceuticals Us, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 66215-232 QR Code

< Prev: 66215-201Next: 66215-302 >

Related Discussions:

Lupibose (Bosentan) Uses
What is Lupibose 62.5 mg (Bosentan) used for? ## Lupibose (Bosentan) is used to treat Pulmonary Artery Hypertension. Pos... 2 replies
when will tracleer get out your system
Taking tracleer for ph for years. I'm 26 yrs old & weigh 133 lbs. I was taking 125mg 2x's a day. Blood work ... 1 reply
Tracleer side maffects
I had side effects to Tracleer and now I read that I will die without it. I was diagnosed withPVH 2 yrs ago. Does anyone...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.